This page shows you your search results in order of date.

Order by Relevance | Date

Total 9900 results found since Jan 2013.

Enhancing Use of Medications for Opioid Use Disorder Through External Coaching
CONCLUSIONS: External coaching can increase organizational capacity for and growth of buprenorphine use. Future research should explore the dimensions of coaching practice, dose, and delivery modality to better understand and enhance the coaching function.PMID:36196533 | DOI:10.1176/appi.ps.202100675
Source: Psychiatric Services - October 5, 2022 Category: Psychiatry Authors: Todd Molfenter Hanna Kim Jee-Seon Kim Abby Kisicki Hannah K Knudsen Julie Horst Randy Brown Lynn M Madden Alex Toy Eric Haram Nora Jacobson Source Type: research

Hot off the Press: Medications For Opioid Use Disorder In The Emergency Department
This study explores patient perspectives regarding initiation of MOUD in the ED, including the barriers and facilitators to starting MOUD and the use of shared decision making to improve patient interactions.PMID:36197068 | DOI:10.1111/acem.14602
Source: Accident and Emergency Nursing - October 5, 2022 Category: Emergency Medicine Authors: Christopher Bond Kirsty Challen William K Milne Source Type: research

Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending
This case-control study estimates the association between buprenorphine treatment gaps, opioid overdose, and health care spending.
Source: JAMA Psychiatry - October 5, 2022 Category: Psychiatry Source Type: research

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
CONCLUSION: Application of configurational methods allowed synthesis of case reports identified through a systematic review.PMID:36195895 | DOI:10.1186/s13722-022-00336-z
Source: Addiction Science and Clinical Practice - October 4, 2022 Category: Addiction Authors: Adams K K Miech E J Sobieraj D M Source Type: research

Buprenorphine as a treatment for major depression and opioid use disorder - Namchuk AB, Lucki I, Browne CA.
Rates of major depressive disorder (MDD) are disproportionally high in subjects with opioid use disorder (OUD) relative to the general population. MDD is often more severe in OUD patients, leading to compliance issues with maintenance therapies and poor ou...
Source: SafetyLit - October 3, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder
Am J Psychiatry. 2022 Oct;179(10):699-701. doi: 10.1176/appi.ajp.20220687.NO ABSTRACTPMID:36181331 | DOI:10.1176/appi.ajp.20220687
Source: The American Journal of Psychiatry - October 1, 2022 Category: Psychiatry Authors: Elizabeth C Saunders Source Type: research

Weekly Overseas Health IT Links –1st October, 2022.
This article details information required for integration into EHRs to build personalized treatment plans and develop successful SDOH programs that provide resources and support for patients in need. In addition, successful SDOH programs implemented by Kaiser Permanente and Boston Medical Center showcase how supporting clinicians with real-time SDOH data can lead to patient-centric care. Create a 360-Degree Patient View Through TechnologyThe Office of the National Coordinator for Health Information Technology (ONC)indicatesthat the “collection, documentation, reporting, access, and use of SDOH data … can be used t...
Source: Australian Health Information Technology - October 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder
American Journal of Psychiatry,Volume 179, Issue 10, Page 699-701, October 2022.
Source: American Journal of Psychiatry - October 1, 2022 Category: Psychiatry Authors: Elizabeth C. Saunders Source Type: research

Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network
This study aimed to examine primary care GPs' opinions about buprenorphine and habits related to prescribing buprenorphine.
Source: Journal of Substance Abuse Treatment - September 30, 2022 Category: Addiction Authors: Barbara L épine, Marion Debin, Lise Dassieu, Laetitia Gimenez, Aurore Palmaro, Camille Ponté, Morgane Swital, Maryse Lapeyre-Mestre, Thierry Blanchon, Julie Dupouy Source Type: research

Administration and patient-incurred costs associated with opioid agonist treatment in Norway
CONCLUSION: The analysis showed that the monthly formulation of SC-BPN was the cost-minimising alternative, followed by the weekly formulation, when considering all cost components.PMID:36172758 | DOI:10.1080/03007995.2022.2129230
Source: Current Medical Research and Opinion - September 29, 2022 Category: Research Authors: Mikkel H Pedersen Anne Dan ø Carl Gibbons Rasmus Jensen Source Type: research

Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now
Korean J Pain. 2022 Oct 1;35(4):361-382. doi: 10.3344/kjp.2022.35.4.361.ABSTRACTThe third opium war may have already started, not only due to illicit opioid trafficking from the Golden Crescent and Golden Triangle on the international front but also through indiscriminate opioid prescription and opioid diversion at home. Opioid use disorder (OUD), among unintentional injuries, has become one of the top 4 causes of death in the United States (U.S.). An OUD is defined as a problematic pattern of opioid use resulting in clinically significant impairment or distress, consisting of 2 or more of 11 problems within 1 year, as des...
Source: Korean Journal of Pain - September 29, 2022 Category: Anesthesiology Authors: Eun-Ji Kim Eun-Jung Hwang Yeong-Min Yoo Kyung-Hoon Kim Source Type: research

Administration and patient-incurred costs associated with opioid agonist treatment in Norway
CONCLUSION: The analysis showed that the monthly formulation of SC-BPN was the cost-minimising alternative, followed by the weekly formulation, when considering all cost components.PMID:36172758 | DOI:10.1080/03007995.2022.2129230
Source: Current Medical Research and Opinion - September 29, 2022 Category: Research Authors: Mikkel H Pedersen Anne Dan ø Carl Gibbons Rasmus Jensen Source Type: research